Will the AI Stock Dip Save You Money on Back-to-School Laptops? 2026/08/14 by Ethan Taylor Here’s how Nvidia, semiconductor prices, AI spending and 2026 laptop deals could affect consumer electronic prices.
Anti Ageing Biotech: Are We Close to Slowing, Stopping, or Reversing Ageing? 2026/08/14 by Grace Wilson While drugs like rapamycin and senolytics can slow certain ageing processes, truly stopping or reversing human ageing remains elusive. Emerging reprogramming techniques show promise, but safety and regulatory hurdles still leave healthy habits as today’s best anti-ageing strategy.
AI Agents in the Workplace: Teammate, Tool, or Threat? 2026/08/14 by Grace Wilson Whether AI agents become tools, teammates, or threats depends on how they are deployed. With reskilling and ethical safeguards, they amplify human potential rather than replace it.
The Agent Economy: When Your AI Books Flights, Orders Groceries, and Pays Bills 2026/08/07 by Grace Wilson The agent economy, powered by tools like OpenAI’s Operator, lets AI handle travel bookings, shopping, and payments, promising a trillion-dollar market by 2028 but sparking security and regulatory concerns.
AI-Powered Drones: The Next Generation of Delivery, Surveillance, and Disaster Response 2026/08/06 by Grace Wilson AI drones are reshaping delivery, monitoring, and rescue operations with real-time intelligence and autonomy, but their safe integration into airspace hinges on evolving regulations, strong privacy safeguards, and robust security measures.
Agentic AI Explained: How Large Language Models Became Doers 2026/07/31 by Grace Wilson Agentic AI enables LLMs to plan, use tools, and act autonomously, evolving from chatbots into doers. Key enablers include reasoning, tool calling, and memory, but it also brings safety and hallucination challenges.
Why Would Anyone Destroy a Rare Book After Paying For It? 2026/07/30 by Ethan Taylor AI companies are accused of buying rare books, cutting their spines, scanning them for AI training, and destroying originals.
CRISPR 2.0: Gene Editing Is Getting Faster, Cheaper, and More Precise 2026/07/28 by Grace Wilson CRISPR 2.0 tools such as base and prime editing rewrite DNA with precision, avoiding breaks. They’ve led to approved therapies like Casgevy for sickle cell disease, yet ethical and access challenges remain.